Skip to main content

Urcuyo Delgado, Gabriela

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

Urcuyo Delgado, Gabriela

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

Related news

The donation will enable further characterisation of patients with this rare disease, the identification of new biomarkers and the exploration of innovative therapies.

The clinical trial, which also involved Vall d’Hebron, shows that the new therapy improves survival by 86% in patients with thymidine kinase 2 deficiency (TK2d).

The ClinPrior algorithm achieved a positive diagnosis rate of 70% in two minority diseases of neurodegenerative origin, which represents double the number of cases that are diagnosed with current tools.

Related professionals

Ma Luisa Navarrete Álvaro

Ma Luisa Navarrete Álvaro

Head and Neck Cancer: Biomedical Research Cancer Stem cells
Read more
Cristian Gómez Velasco

Cristian Gómez Velasco

Tècnic/a Superior Recerca
Clinical Trials Management Unit
Clinical Research Development Directorate
Read more
Núria Torquet i Luna

Núria Torquet i Luna

Research technician
Childhood Cancer and Blood Disorders
Read more
José Luis Peiró Ibáñez

José Luis Peiró Ibáñez

Bioengineering, Cell Therapy and Surgery in Congenital Malformations
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.